— Rapid reduction in kidney inflammation following avacopan treatment in patients with ANCA-Associated Vasculitis revealed by analysis of markers of kidney damage —
— Podocyte protection demonstrated with CCR2 inhibitor CCX140, supporting differentiated potential treatment option for patients with Focal Segmental Glomerulosclerosis —